Ulrich Heininger

Q: What Schools Are Affiliated With Ulrich Heininger

Ulrich Heininger is affiliated with the following schools: University of California, Los Angeles, University of Basel

Ulrich Heininger's AcademicInfluence.com Rankings

Ulrich Heininger

Medical

#3389

World Rank

#3857

Historical Rank

Pediatrics

#85

World Rank

#99

Historical Rank

Epidemiology

#650

World Rank

#676

Historical Rank

medical Degrees

Ulrich Heininger

Philosophy

#9705

World Rank

#13303

Historical Rank

Logic

#6674

World Rank

#8213

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Ulrich Heininger's Degrees

Doctorate Medicine University of Basel
PhD Epidemiology University of Basel

Why Is Ulrich Heininger Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ulrich Heininger's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study (2020) (855)
Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. (2011) (504)
A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT Vaccine (1998) (498)
A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. (1998) (428)
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. (2007) (334)
Comparison of the Efficacy and Safety of Live Attenuated Cold-Adapted Influenza Vaccine, Trivalent, With Trivalent Inactivated Influenza Virus Vaccine in Children and Adolescents With Asthma (2006) (279)
Rationale for pertussis booster vaccination throughout life in Europe. (2011) (248)
Defining Pertussis Epidemiology: Clinical, Microbiologic and Serologic Perspectives (2005) (208)
New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. (2004) (182)
Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. (1994) (173)
Three-Year Surveillance of Intussusception in Children in Switzerland (2007) (172)
Influenza-Associated Myositis in Children (2004) (172)
The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). (2002) (151)
Pertussis in German adults. (1995) (149)
Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013 (2015) (143)
Pertussis Across the Globe: Recent Epidemiologic Trends From 2000-2013. (2015) (134)
Vaccination policies for health-care workers in acute health-care facilities in Europe. (2011) (133)
Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study. (1997) (132)
Neonatal Sepsis of Early Onset, and Hospital‐Acquired and Community‐Acquired Late Onset: A Prospective Population‐Based Cohort Study (2018) (131)
International variation in disease burden of rotavirus gastroenteritis in children with community- and nosocomially acquired infection. (2001) (109)
Varicella (2006) (105)
Diagnosis of acute haematogenous osteomyelitis and septic arthritis: 20 years experience at the University Children's Hospital Basel. (2001) (99)
An internet-based survey on parental attitudes towards immunization. (2006) (99)
Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents (2005) (97)
A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants. (2004) (96)
Procalcitonin Guidance to Reduce Antibiotic Treatment of Lower Respiratory Tract Infection in Children and Adolescents (ProPAED): A Randomized Controlled Trial (2013) (94)
Neither the Bvg− Phase nor thevrg6 Locus of Bordetella pertussis Is Required for Respiratory Infection in Mice (1998) (93)
Bordetella pertussis. (2016) (90)
Health Burden of Pertussis in Infants and Children (2005) (88)
Comparative varicella vaccine effectiveness during outbreaks in day-care centres. (2010) (83)
The development of standardized case definitions and guidelines for adverse events following immunization. (2007) (83)
Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study. (2017) (83)
Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? (2012) (81)
How Do Physicians Immunize Their Own Children? Differences Among Pediatricians and Nonpediatricians (2005) (81)
Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine (2002) (81)
Update on pertussis in children (2010) (77)
Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data. (2007) (76)
Vaccination of healthcare personnel in Europe: Update to current policies. (2019) (75)
Clinical Validation of a Polymerase Chain Reaction Assay for the Diagnosis of Pertussis by Comparison With Serology, Culture, and Symptoms During a Large Pertussis Vaccine Efficacy Trial (2000) (75)
Vaccination of healthcare personnel in Europe: Update to current policies. (2019) (75)
Influenza Vaccination Among Healthcare Workers in a University Children's Hospital (2005) (72)
Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review (2020) (70)
TRANSPLACENTALLY ACQUIRED IMMUNOGLOBULIN G ANTIBODIES AGAINST MEASLES, MUMPS, RUBELLA AND VARICELLA-ZOSTER VIRUS IN PRETERM AND FULL TERM NEWBORNS (2004) (68)
Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany. (1994) (67)
The concept of vaccination failure. (2012) (66)
Global alignment of immunization safety assessment in pregnancy - The GAIA project. (2016) (66)
Comparative Efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pertussis Vaccine Study Group. (1998) (64)
Metaanalysis of vaccine effectiveness in varicella outbreaks. (2007) (64)
All that palsies is not Bell's -the need to define Bell's palsy as an adverse event following immunization. (2007) (63)
Gastrointestinal pathogens detected by multiplex nucleic acid amplification testing in stools of pediatric patients and patients returning from the tropics (2014) (63)
Serologic response and antibody-titer decay in adults with pertussis. (2004) (62)
Intussusception: Incidence and Treatment—Insights From the Nationwide German Surveillance (2011) (58)
Protecting newborns from pertussis – the challenge of complete cocooning (2014) (58)
Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants. (2004) (58)
Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany (1995) (58)
A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data (2017) (57)
Seroprevalence and immunization history of selected vaccine preventable diseases in medical students. (2005) (57)
Serious pertussis overlooked in infants (1992) (56)
Apnoea and bradycardia in preterm infants following immunisation with pentavalent or hexavalent vaccines (2005) (55)
Prevalence of Nosocomial Infections in Swiss Children's Hospitals (2004) (54)
Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age. (2006) (53)
Outbreak investigation for toxigenic Corynebacterium diphtheriae wound infections in refugees from Northeast Africa and Syria in Switzerland and Germany by whole genome sequencing. (2016) (53)
Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement (2020) (53)
Immunization stress-related response - Redefining immunization anxiety-related reaction as an adverse event following immunization. (2020) (53)
Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis. (2004) (52)
Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization (2017) (51)
The Brighton Collaboration: enhancing comparability of vaccine safety data (2003) (50)
Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity (2001) (49)
PERISCOPE: road towards effective control of pertussis. (2019) (48)
Immunization rates and timely administration in pre-school and school-aged children (2006) (47)
Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age. (2000) (47)
Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses. (2007) (47)
The Brighton Collaboration: Creating a Global Standard for Case Definitions (and Guidelines) for Adverse Events Following Immunization (2005) (47)
Antibody Response Patterns to Bordetella pertussis Antigens in Vaccinated (Primed) and Unvaccinated (Unprimed) Young Children with Pertussis (2010) (47)
Comparison of clinical characteristics of influenza and respiratory syncytial virus infection in hospitalised children and adolescents (2004) (46)
Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentation. (2007) (44)
Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013 (2016) (44)
Recent progress in clinical and basic pertussis research (2001) (44)
Comparative Phenotypic Analysis of the Bordetella parapertussis Isolate Chosen for Genomic Sequencing (2002) (44)
Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies. (2009) (43)
Multiple herpetic whitlow lesions in a 4-year-old girl: case report and review of the literature (2001) (43)
Molecular epidemiology of the nasal colonization by methicillin-susceptible Staphylococcus aureus in Swiss children. (2010) (43)
Attitudes of pediatricians regarding influenza self-immunization: a survey in a Swiss university children’s hospital (2003) (42)
MATERNALLY DERIVED ANTIBODIES AGAINST BORDETELLA PERTUSSIS ANTIGENS PERTUSSIS TOXIN AND FILAMENTOUS HEMAGGLUTININ IN PRETERM AND FULL TERM NEWBORNS (2009) (42)
Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection. (1999) (41)
The Protective Role of Maternally Derived Antibodies Against Bordetella Pertussis in Young Infants (2013) (41)
Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women. (2016) (41)
Randomized, comparative efficacy trial of oral penicillin versus cefuroxime for perianal streptococcal dermatitis in children. (2008) (40)
Standardized case definitions of adverse events following immunization (AEFI). (2004) (40)
Epidemiology of tick-borne encephalitis in Switzerland, 2005 to 2011. (2014) (39)
Children and adolescents in the CoVid-19 pandemic: Schools and daycare centers are to be opened again without restrictions. The protection of teachers, educators, carers and parents and the general hygiene rules do not conflict with this (2020) (39)
Bordetella pertussis infections and sudden unexpected deaths in children (1996) (39)
Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as Causative Agents of Community-Acquired Pneumonia in Hospitalised Children and Adolescents (2003) (39)
The Swiss National Registry for Primary Immunodeficiencies: report on the first 6 years’ activity from 2008 to 2014 (2015) (39)
Pertussis immunisation in adolescents and adults – Bordetella pertussis epidemiology should guide vaccination recommendations (2006) (38)
Adverse events following immunization: perception and evidence (2007) (38)
Brevibacterium casei Sepsis in an 18-Year-Old Female with AIDS (2000) (37)
Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems. (2009) (37)
Prospective pertussis surveillance in Switzerland, 1991-2006. (2011) (37)
The Effect of Investigator Compliance (Observer Bias) on Calculated Efficacy in a Pertussis Vaccine Trial (1998) (35)
Initial presenting manifestations in 16,486 patients with Inborn Errors of Immunity include infections and non-infectious manifestations. (2021) (35)
Reliability of varicella history in children and adolescents. (2005) (35)
Vaccinated students with negative enzyme immunoassay results show positive measles virus-specific antibody levels by immunofluorescence and plaque neutralisation tests. (2007) (34)
Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany. (1993) (34)
Analysis of proteins encoded by the ptx and ptl genes of Bordetella bronchiseptica and Bordetella parapertussis (1996) (34)
Humoral immunity against diphtheria, tetanus and poliomyelitis after antineoplastic therapy in children and adolescents--a retrospective analysis. (2000) (34)
Pertussis vaccines (1999) (33)
Unexplained sudden death, including sudden infant death syndrome (SIDS), in the first and second years of life: case definition and guidelines for collection, analysis, and presentation of immunization safety data. (2007) (33)
Irregular tick-borne encephalitis vaccination schedules: the effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study. (2014) (33)
Prospective study on central venous line associated bloodstream infections (2011) (32)
Swiss consensus recommendations on urinary tract infections in children (2020) (32)
Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data. (2017) (32)
A 4-year study on clinical characteristics of children hospitalized with rotavirus gastroenteritis (2009) (31)
Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. (2004) (31)
The Role of Bordetella Infections in Patients with Acute Exacerbation of Chronic Bronchitis (2005) (31)
Reporting of vaccine safety data in publications: systematic review (2005) (30)
Global Review of the Age Distribution of Rotavirus Disease in Children Aged <5 Years Before the Introduction of Rotavirus Vaccination (2019) (30)
The Parental Appraisal of the Morbidity of Diarrhea in Infants and Toddlers (PAMODI) Survey (2008) (29)
The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in respiratory mouse model. (1998) (29)
Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany (1993) (28)
Acceptance and timeliness of standard vaccination in children with chronic neurological deficits in north-western Switzerland (2005) (28)
Surveillance for adverse events following immunization (AEFI) in Switzerland--1991-2001. (2010) (27)
Pertussis: what the pediatric infectious disease specialist should know. (2012) (27)
Pertussis in German adults (1994) (27)
The success of immunization-shovelling its own grave? (2004) (26)
The Brighton Collaboration-enhancing vaccine safety. (2004) (26)
Rational diagnostic strategies for Lyme borreliosis in children and adolescents: recommendations by the Committee for Infectious Diseases and Vaccinations of the German Academy for Pediatrics and Adolescent Health (2012) (25)
Prospective Nationwide Surveillance of Hospitalizations Due to Pertussis in Children, 2006–2010 (2013) (25)
Human metapneumovirus infections—biannual epidemics and clinical findings in children in the region of Basel, Switzerland (2009) (25)
Assessment of varicella vaccine effectiveness in Germany: a time-series approach (2010) (25)
Update of the Swiss guidelines on post-treatment Lyme disease syndrome. (2016) (25)
Incidence and Outcome of Group B Streptococcal Sepsis in Infants in Switzerland (2016) (25)
Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update. (2018) (25)
No temporal association between influenza outbreaks and invasive pneumococcal infections (2007) (25)
Evaluation of the current use of imaging modalities and pathogen detection in children with acute osteomyelitis and septic arthritis (2018) (24)
Economic evaluation of varicella vaccination in Swiss children and adolescents (2009) (24)
Compliance with antenatal screening for hepatitis B surface antigen carrier status in pregnant women and consecutive procedures in exposed newborns (2004) (24)
Immunogenicity and reactogenicity of a single dose of a diphtheria--tetanus--acellular pertussis component vaccine (DTaP) compared to a diphtheria--tetanus toxoid (Td) and a diphtheria toxoid vaccine (d) in adults. (2001) (24)
Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children—A Systematic Review and Meta-Analysis (2019) (23)
PREVALENCE OF NASAL COLONIZATION WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) IN CHILDREN A MULTICENTER CROSS-SECTIONAL STUDY (2007) (23)
Successful control of a pertussis outbreak in a university children's hospital. (2008) (22)
[Herpes simplex virus type 1 and 2 in Switzerland]. (2000) (22)
Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy☆ (2016) (22)
Controlling pertussis: how can we do it? A focus on immunization (2018) (22)
Assessment of immunization status in hospitalized children followed by counseling of parents and primary care physicians improves vaccination coverage: an interventional study. (2007) (22)
Pertussis immunisation in adolescents and adults. (2008) (22)
Etiology of Aseptic Meningitis, Peripheral Facial Nerve Palsy, and a Combination of Both in Children (2010) (21)
Kinetics of maternally acquired anti-hepatitis A antibodies: prediction of waning based on maternal or cord blood antibody levels. (2013) (21)
A Retrospective Analysis of Nosocomial Viral Gastrointestinal and Respiratory Tract Infections (2012) (21)
Evaluation of the Compliance With Recommended Procedures in Newborns Exposed to HBsAg-Positive Mothers: A Multicenter Collaborative Study (2010) (21)
Time-to-Positivity of Blood Cultures in Children With Sepsis (2018) (20)
Fever following immunization (2005) (20)
Vaccination of health care workers against pertussis: meeting the need for safety within hospitals. (2014) (20)
Prospective Surveillance of Nosocomial Viral Infections During and After Hospitalization at a University Children's Hospital (2010) (19)
Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in Switzerland. (2021) (19)
Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression (2016) (19)
Template protocol for clinical trials investigating vaccines--focus on safety elements. (2013) (19)
Interpretation of primary care physicians' attitude regarding rotavirus immunisation using diffusion of innovation theories. (2009) (19)
Bacterial colonization of VEPTR implants under repeated expansions in children with severe early onset spinal deformities (2016) (19)
Measles Status-Barriers to Vaccination and Strategies for Overcoming Them. (2018) (19)
Early Appearance of Bactericidal Antibodies after Polysaccharide Challenge of Toddlers Primed with a Group C Meningococcal Conjugate Vaccine: What Is Its Role in the Maintenance of Protection? (2006) (19)
Current status of Bacille Calmette Guérin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines. (2015) (19)
Is There a Need for a Stand-alone Acellular Pertussis Vaccine? (2017) (18)
Evaluation of the Brighton Collaboration case definition of acute intussusception during active surveillance. (2006) (18)
[Rotavirus gastroenteritis in infants and children. Results of a prospective study in the area of Geneva and Basel 1997/1998 (RoMoS). RoMoS Study Group]. (1999) (18)
Successful hepatitis B immunization in non- and low responding health care workers (2010) (18)
A multicenter, cross-sectional study on the prevalence and risk factors for nasal colonization with Staphylococcus aureus in patients admitted to children's hospitals in Switzerland. (2008) (18)
Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease (2015) (17)
Burden of Streptococcus pneumoniae sepsis in children after introduction of pneumococcal conjugate vaccines - a prospective population-based cohort study. (2019) (17)
Clinical findings and unusual epidemiologic characteristics of human metapneumovirus infections in children in the region of Basel, Switzerland (2007) (17)
Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group. (1997) (17)
Symptomatic Congenital Cytomegalovirus Infection in Children of Seropositive Women (2017) (16)
Hospital-associated infections in children: a prospective post-discharge follow-up survey in three different paediatric hospitals. (2012) (16)
Rotavirus Disease in Germany—A Prospective Survey of Very Severe Cases (2013) (16)
Human transmissible spongiform encephalopathies. (1998) (16)
Scarlet Fever Associated with Hepatitis – A Report of Two Cases (2000) (16)
Comparative Analysis of Clinical Characteristics of Pandemic Influenza A/H1n1 and Seasonal Influenza A Infections in Hospitalized Children (2012) (15)
Herpes zoster and aseptic meningitis in a previously healthy child (2003) (15)
The utility of serologic testing for varicella in an adolescent population. (2002) (15)
OSH Manual of Childhood Infections: The Blue Book (2016) (15)
Brain abscesses in neonates — report of three cases (1993) (15)
Compliance with recommended immunizations in adolescents (2006) (15)
Do We Know When, What and For How Long to Treat?: Antibiotic Therapy for Pediatric Community-acquired Pneumonia (2012) (14)
[Seroprevalence of IgG antibodies against measles, mumps and rubella in Swiss children during the first 16 months of life]. (2000) (14)
Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections (2017) (14)
Emerging macrolide resistance in Bordetella pertussis in mainland China: Findings and warning from the global pertussis initiative (2021) (14)
Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR) (2021) (14)
Bordetella pertussis and Concomitant Viral Respiratory Tract Infections Are Rare in Children With Cough Illness (2011) (14)
How to improve communication on vaccine issues at the national level? INFOVAC-PED: an example from Switzerland. (2001) (14)
Plasma lipid profiles discriminate bacterial from viral infection in febrile children (2019) (13)
Drivers of antibiotic prescribing in children and adolescents with febrile lower respiratory tract infections (2017) (13)
The Susceptibility to Other Infectious Diseases Following Measles During a Three Year Observation Period in Switzerland (2020) (13)
Comparative acceptance of pertussis and influenza immunization among health-care personnel. (2015) (13)
Evaluating the Brighton Collaboration case definitions, aseptic meningitis, encephalitis, myelitis, and acute disseminated encephalomyelitis, by systematic analysis of 255 clinical cases. (2010) (13)
Post-exposure prophylaxis for measles with immunoglobulins revised recommendations of the standing committee on vaccination in Germany. (2018) (13)
Antibiotic treatment of pertussis: are 7 days really sufficient? (2015) (12)
Mycoplasma pneumoniae detection in children with respiratory tract infections and influence on management – a retrospective cohort study in Switzerland (2019) (11)
Pertussis: an old disease that is still with us. (2001) (11)
Pertussis: an old disease that is still with us (2001) (11)
Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland (2009) (11)
PROTECTION AGAINST VACCINE-PREVENTABLE DISEASES IN MEDICAL STUDENTS (2003) (11)
Implementation of pertussis immunization in health-care personnel. (2015) (11)
Comparison of pulsed field gel electrophoresis patterns of Bordetella pertussis isolates from unvaccinated children with severe or mild pertussis (2004) (11)
Determinants of SARS-CoV-2 transmission to guide vaccination strategy in a city (2020) (11)
Comparative Coverage of Supplementary and Universally Recommended Immunizations in Children at 24 Months of Age (2012) (10)
Surrogate Serologic Tests for the Prediction of Pertussis Vaccine Efficacy a (1995) (10)
A risk-benefit analysis of vaccination. (2009) (9)
Guide to active vaccine safety surveillance: Report of CIOMS working group on vaccine safety - executive summary. (2017) (9)
Demonstration of perivascular echogenicities in congenital cytomegalovirus infection by colour Doppler imaging (1990) (9)
Health Impact and Cost-effectiveness Assessment for the Introduction of Universal Varicella Vaccination in Switzerland (2021) (9)
[Prevalence of perianal streptococcal dermatitis in children and adolescents]. (2005) (9)
Enterovirus detection in patients with acute gastroenteritis in Switzerland (2018) (9)
Prospective multinational serosurveillance study of Bordetella pertussis infection among 10- to 18-year-old Asian children and adolescents. (2019) (9)
Prospective Nationwide Surveillance of Hospitalizations due to Pertussis in Children, 2006-2010. (2013) (9)
[Tick bite and Lyme borreliosis. An epidemiologic study in the Erlangen area]. (1993) (9)
Economic burden of varicella in Europe in the absence of universal varicella vaccination (2021) (9)
An Efficacy Trial in Erlangen, Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP Vaccine (DTaP) or the Lederle Whole-Cell Component DTP Vaccine (DTP). • 714 (1997) (9)
[Pertussis vaccination coverage among adults in Germany]. (2013) (8)
Immunogenicity and safety of a monovalent, multicomponent acellular pertussis vaccine in 15 month-6-year-old German children. Monovalent Acellular Pertussis Vaccine Study Group. (1995) (8)
Clinical characteristics and outcomes in children hospitalised with pandemic influenza A/H1N1/09 virus infection – a nationwide survey by the Pediatric Infectious Diseases Group of Switzerland. (2015) (8)
Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants. (2005) (8)
Coverage rates and timeliness of nationally recommended vaccinations in Swiss preschool children: A descriptive analysis using claims data. (2019) (8)
Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. (2021) (8)
Health Care–Associated Rotavirus Illness in Pediatric Inpatients in Germany, Austria, and Switzerland (2006) (8)
Child-parent immunization survey: How well are national immunization recommendations accepted by the target groups? (2019) (7)
Optimal Tobramycin Dosage in Patients with Cystic Fibrosis – Evidence for Predictability Based on Previous Drug Monitoring (1999) (7)
Interstrain antigenic variability of mumps viruses. (2008) (7)
Whole-exome Sequencing for the Identification of Rare Variants in Primary Immunodeficiency Genes in Children With Sepsis: A Prospective, Population-based Cohort Study (2020) (7)
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately. (2020) (7)
Protection Against Vaccine-preventable Diseases in Medical Students: A Follow Up (2014) (6)
Hepatitis B Postexposure Prophylaxis in Preterm and Low-Birth-Weight Infants (2015) (6)
Global Vaccine Safety Assessment: Challenges and Opportunities. (2016) (6)
Syphilis of Children (1901) (6)
Human but not ovine isolates ofBordetella parapertussis are highly clonal as determined by PCR-based RAPD fingerpringting (1998) (6)
Advance system testing: Vaccine benefit studies using multi-country electronic health data - The example of pertussis vaccination. (2020) (6)
Stop tuberculosis! (2003) (6)
Borrelia lymphocytoma (“lymphadenosis benigna cutis”) (2002) (6)
Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group. (1997) (6)
Prospective, cross-sectional study on MSSA and MRSA colonisation in hospitalised children (2015) (5)
Pertussis and Other Bordetella Infections of the Respiratory Tract (2019) (5)
Early prevention of pertussis is key. (2019) (5)
Pertussis vaccination in mixed markets: recommendations from the Global Pertussis Initiative. (2020) (5)
Group A Streptococcal Suppurative Arthritis and Osteomyelitis of the Shoulder With Brachial Plexus Palsy in a Newborn. (2016) (5)
Simultaneous palsy of facial and vestibular nerve in a child with Lyme borreliosis (1990) (4)
The Comparative Efficacy of the Lederle/Takeda Acellular Pertussis Component DTaP Vaccine and Lederle Whole-Cell Component DTP Vaccine in German Infants Following Household Exposure • 846 (1998) (4)
Addressing the needs and gaps in safety assessment of vaccines during clinical trials in resource limited countries. (2011) (4)
Attitudes of Swiss Health Care Providers Toward Childhood Immunizations (2017) (4)
New immunisation recommendations in Germany (2002) (4)
Dose-dependent effectiveness of acellular pertussis vaccine in infants: A population-based case-control study. (2019) (4)
Case report: when two and ½ men go camping… (2017) (4)
Lemierre syndrome and nosocomial transmission of Fusobacterium necrophorum from patient to physician. (2010) (4)
An update on the prevention of influenza in children and adolescents (2003) (4)
The respiratory pathology in infants with sudden unexpected deaths in whom respiratory specimens were initially PCR-positive or PCR-negative for Bordetella pertussis (2011) (4)
Pertussis incidence rates in Novi Sad (Serbia) before and during improved surveillance (2017) (4)
Discrimination of Bordetella parapertussis and Bordetella pertussis organisms from clinical isolates by PCR using biotin-labelled oligonucleotide probes. (1998) (4)
Strikingly Decreased Community-acquired Pneumonia Admissions in Children Despite Open Schools and Day-care Facilities in Switzerland. (2020) (4)
Paediatric refugees from Ukraine: guidance for health care providers. (2022) (4)
Measles Morbidity and Mortality in the Developed World are Greater than the Public Perceives (2017) (3)
What Matters to Parents Regarding Immunization of Their Children (2019) (3)
EUROPE CALLING (2000) (3)
[Current aspects in diagnosis and therapy of pediatric facial paralysis]. (1994) (3)
Corrigendum to “Comparative Varicella vaccine effectiveness during outbreaks in day care centers” [Vaccine 28 (2010) 686–691] (2010) (3)
[Aminoglycosides in patients with mucoviscidosis and pulmonary exacerbation. Comparison of once or three times daily administration]. (1993) (3)
A systematic review of safety data reporting in clinical trials of vaccines against malaria, tuberculosis, and human immunodeficiency virus. (2013) (3)
[Complications of infectious diseases and benefits of immunization]. (2004) (3)
Akute Otitis media (2008) (3)
Group A streptococcal disease in paediatric inpatients: a European perspective (2022) (3)
PIN6 EPIDEMIOLOGIC AND ECONOMIC IMPACT OF ROUTINE VACCINATION OF INFANTS AGAINST ROTAVIRUS GASTROENTERITIS IN GERMANY: A PRELIMINARY ANALYSIS (2007) (3)
Ulceroglandular Tularemia Following Contact with a Boar. (2016) (3)
Immunogenicity and safety of a monovalent, multicomponent acellular pertussis vaccine in 15 month–6-year-old German children (1995) (3)
[Congenital Langerhans-cell histiocytosis presenting as a varicella infection]. (1999) (3)
The persistence of pertussis and developments in vaccination strategies. (2015) (3)
The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections (2022) (2)
Diagnosing tuberculosis (2005) (2)
[Rational use of oral antibiotics in children and young people. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy ]. (2002) (2)
Introduction of pneumococcal vaccine to standard immunisation programmes in Europe: what are we waiting for? (2002) (2)
Update of the Swiss guidelines on post-treatment Lyme disease syndrome. (2016) (2)
[Travel vaccinations in rheumatic diseases : Specific considerations in children and adults]. (2020) (2)
[Papilledema and acute bilateral amaurosis accompanying acute sinusitis]. (2001) (2)
Preventive medicines: vaccination, prophylaxis of infectious diseases, disinfectants. (2011) (2)
Randomised placebo-controlled multicentre effectiveness trial of adjunct betamethasone therapy in hospitalised children with community-acquired pneumonia: a trial protocol for the KIDS-STEP trial (2020) (2)
Mycobacterium bohemicum--a cause of paediatric cervical lymphadenitis. (2004) (2)
Decline of pertussis in hospitalised children following the introduction of immunisation in pregnancy - results from a nationwide, prospective surveillance study, 2013-2020. (2021) (2)
SARS-CoV-2/COVID-19 hospitalised patients in Switzerland: a prospective cohort profile (2020) (2)
Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area (2022) (2)
SwissPedData: Standardising hospital records for the benefit of paediatric research (2021) (2)
World wide wasting? (2001) (2)
Facial palsy with elevated protein in otherwise normal CSF in a child with lyme disease (1991) (2)
Coincidence is not causality—a principle which needs regular rediscovery (2000) (2)
Pertussis in Asia: Recent country-specific data and recommendations. (2022) (2)
Clinical data for paediatric research: the Swiss approach (2021) (2)
Reimmunization after blood or marrow stem cell transplantation: Reply to S Singhal and J Mehta (2000) (2)
Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis Initiative (2022) (1)
Shortage of vaccines: USA, Europe, who next? (2002) (1)
Hypothyroidism, Congenital (2005) (1)
Diphtheria, Tetanus, and Pertussis: Unequal Vaccine Siblings With Distinct Characteristics. (2020) (1)
[Salmonella enteritidis infection presenting with septic shock, renal failure and cutaneous manifestations]. (2009) (1)
[The microagglutination test--a simple and sensitive procedure for serodiagnosis of pertussis infections]. (1995) (1)
Acceptance of universal varicella vaccination among Swiss pediatricians and general practitioners who treat pediatric patients (2021) (1)
Posttreatment Lyme Disease Syndrome-What It Might Be and What It Is Not. (2021) (1)
Guideline adherence in febrile children below 3 months visiting European Emergency Departments: an observational multicenter study (2022) (1)
Titerphilia - The Irresistible Urge to Measure Postimmunization Antibody Values. (2022) (1)
Varicella prevention - a lifelong and challenging affair. (2016) (1)
Perianal Streptococcal Dermatitis is not a Major Cause of Constipation in Pediatric Patients with Cerebral Palsy (2014) (1)
Streptococcus pyogenes Endocarditis Associated With Varicella—Case Report and Review of the Literature (2019) (1)
Two Distinct Episodes Of Whooping Cough Caused By Consecutive Bordetella Pertussis And Bordetella Parapertussis Infections In A Fully Immunized Healthy Boy. (2016) (1)
Influenza-like symptoms and thrombocytopenia in a teenager. (2003) (1)
Comment: Clinical Implications of Endotoxin Concentrations in Vaccines (2002) (1)
[Pertussis (whooping cough)]. (2013) (1)
Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it? (2022) (1)
Acute Hemiparesis Revealing Neuroborreliosis in a 3-Year-Old Boy (2015) (1)
Maternal immunization is not the same as immunization in pregnancy (2015) (1)
Eradication of poliomyelitis: where do we stand in Europe? (2001) (1)
Pertussis in India: Past, Present, and Future (2022) (1)
PS-212 Epidemiology Of Neonatal Sepsis In Switzerland – Results From The Swiss Paediatric Sepsis Study (2014) (1)
Diphtheria, tetanus and pertussis: unequal vaccine siblings with distinct characteristics. (2020) (1)
Preventive measures for accompanying caregivers of children in paediatric health care during the COVID-19 pandemic—walking an ethical tightrope (2021) (1)
Bullous rash in an adolescent girl. (2015) (1)
Accuracy of ICD-10 coding for sepsis and organ dysfunctions in children with blood culture-proven sepsis in Switzerland, results from the prospective Swiss Pediatric Sepsis Study (2019) (1)
Long-Term Outcomes of Acute Osteoarticular Infections in Children (2020) (1)
[Biodegradable nano-polymer agent, an analogue of heparan sulfate, in therapy-refractory varicella keratitis]. (2014) (0)
[Pertussis in adults: symptoms, epidemiology and prevention]. (2001) (0)
Uncomplicated Acute Bronchitis (2001) (0)
Table 2, Levels of evidence for a reported event meeting the case definition (2005) (0)
OP052 [Infections » Sepsis]: VALIDATION OF PEDIATRIC ORGAN DYSFUNCTION SCORES IN CHILDREN WITH BLOODCULTURE PROVEN INFECTION – A NATIONAL PROSPECTIVE COHORT STUDY (2022) (0)
Radioisotopic methods for assay of the enzymes in the urea cycle: First trimester diagnostic possibilities for urea cycle disorders using chorionic villi sampling (1987) (0)
Table 1, Case definitions and guidelines for adverse events following immunization (AEFIs), finalized and under development by the Brighton Collaboration, April 2004 (2005) (0)
26 Hepatitis B (2012) (0)
Referring to: Wilkinson K, Righolt CH, Elliott LJ, Fanella S, Mahmud SM. Pertussis vaccine effectiveness and duration of protection - a systematic review and meta-analysis. Vaccine. 2021 May 27;39(23):3120-3130. (2022) (0)
Do fathers care about their own immunisation status? The Child-Parent-Immunisation Survey and a review of the literature. (2020) (0)
The Effect of Observer Bias in Pertussis Vaccine Efficacy Trials. • 436 (1997) (0)
Ancient methicillin-resistant Staphylococcus aureus: expanding current knowledge using molecular epidemiological characterization of a Swiss legacy collection (2023) (0)
Parental Appraisal of the Morbidity of Diarrhea in Infants (Pamodi-Study): Results and Correlation of Subjective Appraisal with a Clinical Measure of Disease Severity (2007) (0)
Figure 1, Organizational framework of the Brighton Collaboration concerning adverse events following immunization (AEFIs) (2005) (0)
Chapter 36 – Pertussis and Other Bordetella Infections of the Respiratory Tract (2006) (0)
Violent off ending by UK veterans (2013) (0)
26 Coronavirus (inklusive SARS) (2013) (0)
Figure 2, Global collaboration-Graphing the increase in the number of countries and participants involved in the Brighton Collaboration from 2000-April 2004 (2005) (0)
Tick-Borne Encephalitis Vaccines (2021) (0)
[An unusual late manifestation of hemorrhage caused by vitamin K deficiency]. (1989) (0)
Corrigendum: Specifically increased rate of infections in children post measles in a high resource setting (2022) (0)
6 Antimikrobielle Chemotherapie (2013) (0)
Febrile illness in high-risk children: a prospective, international observational study (2022) (0)
[Pertussis--an illness with typical clinical symptoms?]. (1992) (0)
Harmonized case definitions for endpoints in vaccine efficacy trials are needed. (2022) (0)
Clinical and Epidemiologic Characteristics of Pertussis in Hospitalized Children: A Prospective and Standardized Long-term Surveillance Study (2020) (0)
Pneumococcal conjugate vaccines: epidemiology guides clinical use. (2011) (0)
[Influenza in children--an epidemiological problem]. (2007) (0)
The Impact of Australian Childhood Vaccination Mandates on Immunization Specialists and Their Interactions With Families (2022) (0)
Specifically Increased Rate of Infections in Children Post Measles in a High Resource Setting (2022) (0)
Paediatric and neonatal infections 237 Adverse events following immunization: perception and evidence. (2007) (0)
Book review (2005) (0)
The Best of ESPID 2010: 28th ESPID Annual Meeting in Nice, France (2010) (0)
Detection of mostly viral pathogens and high proportion of antibiotic treatment initiation in hospitalised children with community-acquired pneumonia in Switzerland - baseline findings from the first two years of the KIDS-STEP trial. (2023) (0)
PIN86 CLINICAL AND ECONOMIC OUTCOMES ASSOCIATED WITH VARYING COVERAGE OF VARICELLA VACCINATION STRATEGIES IN SWITZERLAND (2019) (0)
27 Hepatitis C, D, E (2012) (0)
[Shock behavior state after vaccination in children--should you continue vaccination?]. (2004) (0)
[Tumor necrosis factor in the serum--a useful supplemental parameter in the diagnosis of infection in cystic fibrosis?]. (1991) (0)
Standardised case definitions for adverse events following immunisation (2013) (0)
Evaluation of the diagnostic utility of the new clinical case definition of pertussis - experience from sentinel and hospital-based pertussis surveillance (2019) (0)
Question 1: Should newborns of mothers with isolated antibodies to hepatitis B core antigen be immunised? (2014) (0)
Comparative Study of Lederle Acellular Pertussis Component APDT and Whole-cell DTP Vaccines in Infants in Germany (1993) (0)
Meropenem-associated severe neutropenia in an infant with brain abscess (2013) (0)
[Special aspects of borreliosis in childhood]. (1999) (0)
SARS-CoV-2 in schools: genome analysis shows that concurrent cases in the second and third wave were often unconnected (2022) (0)
Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial (2023) (0)
Considerations for unblinding individual study participants during vaccine trials. (2023) (0)
Pertussis-like illness is not the same as pertussis (2021) (0)
Prospective surveillance of hospitalisation due to intussusception and association with rotavirus infection in children (2006) (0)
Comment on findings of Hodge et al. (2004) (0)
Reimmunization May Not Be Necessary in EIA Measles Seronegative HIV-infected Children. (2015) (0)
127 Kawasaki-Syndrom (2013) (0)
25 Hepatitis A (2012) (0)
Children with Pertussis and Unvaccinated (Unprimed) Young Antigens in Vaccinated (Primed) pertussis Bordetella Antibody Response Patterns to (2014) (0)
[Protection with influenza vaccine from bird flu?]. (2007) (0)
Correction to: Swiss consensus recommendations on urinary tract infections in children (2020) (0)
131 Sepsis (außer neonatale Early-onset-Sepsis) (2013) (0)
[Pertussis (whooping cough)]. (2017) (0)
Book review (2005) (0)
54 Larva migrans cutanea (2013) (0)
Postexpositionsprophylaxe durch Impfungen (2004) (0)
Needle length and incidence of local reactions to immunisation. Is there a real benefit for the child? (2001) (0)
Identification of regulatory variants associated with genetic susceptibility to meningococcal disease (2019) (0)
Identification of regulatory variants associated with genetic susceptibility to meningococcal disease (2019) (0)
[On the articles published by Dr. Berndt regarding the HPV vaccination on 11/26/2008]. (2009) (0)
Impfungen (2019) (0)
Prevention of Traveler's Diarrhea: A Call to Reconvene (2008) (0)
CHILDREN'S HOSPITALS (2014) (0)
28 Humane Papillomaviren (HPV) (2012) (0)
Correction to: Febrile illness in high-risk children: a prospective, international observational study (2023) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ulrich Heininger?

Ulrich Heininger is affiliated with the following schools:

University of California, Los Angeles
University of Basel

Ulrich Heininger's Academic­Influence.com Rankings

Ulrich Heininger's Degrees

Why Is Ulrich Heininger Influential?

Ulrich Heininger's Published Works

Published Works

What Schools Are Affiliated With Ulrich Heininger?

Ulrich Heininger's AcademicInfluence.com Rankings